Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

LY-411575 tested in novel animal model of Alzheimer's

July 21, 2004

Therapeutic benefits of mitoxantrone in multiple sclerosis

July 21, 2004

Preclinical efficacy in a task sensitive to Alzheimer's disease

July 20, 2004

Safinamide improves motor function in patients with Parkinson's disease

July 20, 2004

First phase of topical ENT-103 formulation completed

July 20, 2004

Estorra NDA resubmission accepted by FDA

July 20, 2004

Indiplon NDA filings planned for fourth quarter 2004

July 20, 2004

Neurobiological Technologies acquires Empire Pharmaceuticals, expanding pipeline with Viprinex

July 20, 2004

Chinese herbal extract reduces neuron damage in in vitro models of brain aging

July 19, 2004

Divalent metal chelator displays neuroprotective effects on neurons from AD patients

July 19, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...